Stay updated on Timing of Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the Timing of Pembrolizumab in NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe displayed revision/version number updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page history now shows Revision: v3.4.2 added and Revision: v3.4.1 removed; this is a minor maintenance update that does not affect study records or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check77 days agoChange DetectedThe history now adds Revision: v3.4.1 and removes Revision: v3.4.0.SummaryDifference0.0%

- Check93 days agoChange DetectedThe history page adds a glossary toggle, color-coded change indicators explaining additions and deletions, and updates the revision tag to v3.4.0 (from v3.3.4).SummaryDifference0.1%

Stay in the know with updates to Timing of Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.